EDWARDS LIFESCIENCES LIMITED
Get an alert when EDWARDS LIFESCIENCES LIMITED files next
Leroy will email you the moment a new filing lands at Companies House — one short note per filing, nothing else.
Cash
£23m
+44.4% highest in 5 filed years
Net assets
£19m
-47.2% vs 2024
Employees
115
-4.2% vs 2024
Profit before tax
£6.5m
-63.8% vs 2024
Net assets
5-year trend · vs Consumer Discretionary median
Accounts
5-year trend · Δ = latest vs prior filed period · latest reflected 2025-12-31
| Metric | Trend | 2020-12-31 | 2021-12-31 | 2023-12-31 | 2024-12-31 | 2025-12-31 | Δ vs prior |
|---|---|---|---|---|---|---|---|
| Turnover | £107,496,555 | £126,034,595 | £171,393,000 | £197,923,000 | £193,793,000 | -2.1% | |
| Operating profit | £4,441,632 | £5,029,077 | £7,178,000 | £6,672,000 | £5,600,000 | -16.1% | |
| Profit before tax | £4,291,066 | £4,991,697 | £6,655,000 | £18,020,000 | £6,515,000 | -63.8% | |
| Net profit | £3,281,588 | £4,185,345 | £5,451,000 | £13,515,000 | £3,852,000 | -71.5% | |
| Cash | £5,804,975 | £11,637,551 | £18,521,000 | £15,666,000 | £22,623,000 | +44.4% | |
| Total assets less current liabilities | £8,575,140 | £12,968,554 | £22,817,000 | £36,231,000 | £19,115,000 | -47.2% | |
| Net assets | £8,523,332 | £12,916,669 | £22,728,000 | £36,200,000 | £19,114,000 | -47.2% | |
| Equity | £8,523,332 | £12,916,669 | £22,728,000 | £36,200,000 | £19,114,000 | -47.2% | |
| Average employees | 72 | 83 | 106 | 120 | 115 | -4.2% | |
| Wages | £6,388,819 | £7,650,870 | £10,134,000 | £10,963,000 | £12,039,000 | +9.8% | |
| Directors' remuneration | £134,781 | £135,423 | — | — | — | — |
Values shown as filed in the company's annual accounts. — indicates the figure wasn't present under that line item in that period. The Δ column is the change from the prior filed period as a percentage of |prior|; lines a company doesn't report show —. About these numbers
Ratios
Computed from the line items above — sparklines read oldest → newest
| Ratio | Trend | 2020-12-31 | 2021-12-31 | 2023-12-31 | 2024-12-31 | 2025-12-31 |
|---|---|---|---|---|---|---|
| Operating margin | 4.1% | 4.0% | 4.2% | 3.4% | 2.9% | |
| Net margin | 3.1% | 3.3% | 3.2% | 6.8% | 2.0% | |
| Return on capital employed | 51.8% | 38.8% | 31.5% | 18.4% | 29.3% | |
| Gearing (liabilities / total assets) | 71.2% | 63.8% | 68.9% | 53.0% | 72.1% | |
| Current ratio | — | — | 1.45x | 1.88x | 1.38x | |
| Interest cover | 29.50x | — | 13.72x | 23.01x | 21.71x |
Margins divide P&L lines by turnover. Gearing is liabilities over total assets. Current ratio is current assets over creditors falling due within one year. Interest cover is operating profit over absolute finance costs. Sector-distribution context coming next.
Name history
Renamed 2 times since incorporation
- EDWARDS LIFESCIENCES LIMITED 2000-01-13 → present
- EDWARDS LIFE SCIENCES LIMITED 2000-01-04 → 2000-01-13
- INTERCEDE 1510 LIMITED 1999-11-18 → 2000-01-04
Audit & accounting basis
- Accounting basis
- FRS 102
- Reporting scope
- Standalone (parent only)
- Auditor
- Craufurd Hale Audit Services Limited
- Audit opinion
- Unqualified (clean)
- Going concern
- Affirmed
“the directors have concluded that the company has adequate resources to continue in operational existence for the foreseeable future and that there are no material uncertainties that may cast significant doubt upon the company's ability to continue as a going concern.”
Significant events
- “On 3 September 2024, the Critical Care and Vascular ("CCVAS") business was sold to BD (Becton, Dickinson and Company) in an all-cash transaction at group level.”
Auditor, going-concern and subsidiary information is drawn from the narrative of the latest annual accounts. About these numbers
People
3 active · 15 resigned
| Name | Role | Appointed | Born | Nationality |
|---|---|---|---|---|
| CAPPELLE, Patrice Lucien | Director | 2016-05-18 | Aug 1973 | French |
| DAHL, Andrew Michael | Director | 2024-05-15 | Jan 1977 | American |
| PARK, Linda | Director | 2018-05-18 | Dec 1977 | American |
Show 15 resigned officers
| Name | Role | Appointed | Resigned |
|---|---|---|---|
| MITRE SECRETARIES LIMITED | Corporate Nominee Secretary | 1999-11-18 | 2024-05-31 |
| BALLESTER, Andre Michel | Director | 2000-01-14 | 2004-05-28 |
| BEYRATH, Jean-Francois | Director | 2012-09-27 | 2016-05-18 |
| BOTTICELLI, Denise Ellen | Director | 2012-01-05 | 2018-05-18 |
| HARTY, Mark | Director | 2000-02-24 | 2002-04-02 |
| JONES, David Ronald | Director | 2012-01-05 | 2012-09-27 |
| LAURET, Raymond Alex | Director | 2000-01-14 | 2007-07-18 |
| MORRISH, Craig | Director | 2006-09-21 | 2010-01-01 |
| RICH, Michael William | Nominee Director | 1999-11-18 | 2000-01-14 |
| SELLERS, Robert William Armbruster | Director | 2007-07-18 | 2024-05-15 |
| VERGUET, Patrick Bruno | Director | 2007-07-18 | 2012-01-05 |
| WALKER, Nicholas Mark | Director | 2010-01-01 | 2022-03-09 |
| WALTON, Nicholas Peter | Director | 2002-04-03 | 2006-09-21 |
| WARNER, William | Director | 1999-11-18 | 2000-01-14 |
| WERTHEIM, Jay Philip | Director | 2007-07-18 | 2012-01-05 |
Ownership
Persons with significant control
| Name | Kind | Nature of control | Notified | Status |
|---|---|---|---|---|
| Edwards Lifesciences Corporation | Corporate entity | Shares 75–100%, Voting 75–100%, Appoints directors | 2016-04-06 | Active |
Filing timeline
Last 20 of 112 total filings
| Date | Type | Category | Description | |
|---|---|---|---|---|
| 2026-09-15 | AA | accounts | Accounts with accounts type full | |
| 2025-10-14 | CS01 | confirmation-statement | Confirmation statement with no updates | |
| 2025-09-23 | AA | accounts | Accounts with accounts type full | |
| 2024-10-21 | CS01 | confirmation-statement | Confirmation statement with no updates | |
| 2024-10-21 | CH01 | officers | Change person director company with change date | |
| 2024-10-21 | CH01 | officers | Change person director company with change date | |
| 2024-09-27 | AA | accounts | Accounts with accounts type full | |
| 2024-05-31 | TM02 | officers | Termination secretary company with name termination date | |
| 2024-05-17 | AP01 | officers | Appoint person director company with name date | |
| 2024-05-17 | TM01 | officers | Termination director company with name termination date | |
| 2023-10-13 | CS01 | confirmation-statement | Confirmation statement with no updates | |
| 2023-09-28 | AA | accounts | Accounts with accounts type full | |
| 2022-11-18 | CS01 | confirmation-statement | Confirmation statement with no updates | |
| 2022-09-29 | AA | accounts | Accounts with accounts type full | |
| 2022-09-01 | TM01 | officers | Termination director company with name termination date | |
| 2021-11-23 | CS01 | confirmation-statement | Confirmation statement with no updates | |
| 2021-09-29 | AA | accounts | Accounts with accounts type full | |
| 2020-11-30 | AA | accounts | Accounts with accounts type full | |
| 2020-11-19 | CS01 | confirmation-statement | Confirmation statement with no updates | |
| 2019-11-20 | CS01 | confirmation-statement | Confirmation statement with no updates |
Public-record activity
Raw counts from Companies House — last 12–24 months
- Filings
- 2
- Capital events
- 0
- Officers appointed
- 0
- Officers resigned
- 0
last 12 months
last 24 months
last 12 months
last 12 months
Direct counts from the register. No score, no rating — see the Filing timeline for the underlying events.